Medical Condition News

RSS

Brief manualized treatment helps people with problematic caffeine use lower caffeine consumption

Engaging in brief, cognitive-behavioral therapy is an effective treatment for helping people with problematic caffeine use lower their caffeine consumption, according to a new study coauthored by Laura M. Juliano, Ph.D., a professor of psychology at American University.

10 Nov 2015

Type 2 diabetes drug significantly reduces hospitalizations, death from heart failure

For the first time, research shows that a type 2 diabetes drug significantly reduces hospitalizations and death from heart failure.

10 Nov 2015

Two studies explore potential new blood tests for Alzheimer's disease

There is increasing evidence that the brain changes of Alzheimer's disease begin decades before memory and thinking problems occur, prompting the need for better methods of early detection for this progressive, fatal brain disease. Consequently, there is a growing school of thought that the most effective future Alzheimer's drug therapies will be administered to those who are at high risk of the disease before cognitive symptoms appear.

10 Nov 2015

Understanding how schizophrenia affects workings of the brain

Stem cells from adult schizophrenia patients form new proteins more slowly than those from healthy people, according to new research.

10 Nov 2015

Lower socioeconomic status significantly increases risk of pain following knee replacement

Non-white race and lack of education are known risk factors for pain and poorer function after knee replacement surgery. What isn't clear is how a community's poverty level affects the outcomes of having a joint replaced. Findings from a new study conducted by researchers from Hospital for Special Surgery suggest that lower socioeconomic status at the community level significantly increases the risk of pain and poor function following a knee replacement.

10 Nov 2015

UT Southwestern's Helen H. Hobbs named recipient of Breakthrough Prize in Life Sciences

UT Southwestern Medical Center geneticist Dr. Helen H. Hobbs is the 2016 recipient of the prestigious Breakthrough Prize in Life Sciences.

10 Nov 2015

Australian researchers define key characteristics of metabolically healthy obese

Australian researchers have defined some key characteristics of the metabolically healthy obese -- those obese individuals who remain free from type 2 diabetes and other disorders that usually associate with obesity. Their findings have implications for the treatment of type 2 diabetes, insulin resistance and obesity.

10 Nov 2015

Negative body image significantly increases obesity risk among adolescents

Negative body image significantly increases the risk of obesity regardless of whether youth have depression, according to researchers at The University of Texas Health Science Center at Houston School of Public Health.

10 Nov 2015

New review finds scant scientific evidence supporting use of cannabinoids in rheumatic diseases

Although there are anecdotal reports indicating that cannabinoids, especially marijuana (or herbal cannabis), may be of therapeutic benefit for some patients with rheumatic complaints, a new review published in Arthritis Care & Research, a journal of the American College of Rheumatology, finds scant scientific evidence supporting any use of cannabinoids in rheumatic diseases. Furthermore, not a single controlled study has examined herbal cannabis in the rheumatology patient population.

10 Nov 2015

New Cleveland Clinic study shows bariatric surgery is safe option for managing type 2 diabetes in overweight or mildly obese patients

Weight-loss surgery, long considered a treatment largely reserved for people with severe obesity, may also be a good and safe option for the treatment of uncontrolled type 2 diabetes in those who are overweight or have mild to moderate obesity, according to researchers from Cleveland Clinic in Ohio.

10 Nov 2015

Obesity groups take aim at states that deny coverage of obesity treatment under affordable care act

The American Society for Metabolic and Bariatric Surgery (ASMBS) and groups including The Obesity Society (TOS) and Academy for Nutrition and Dietetics (AND), filed a complaint this month with U.S. Health and Human Services (HHS) claiming the 27 states that deny coverage for bariatric surgery are in non-compliance with the Affordable Care Act (ACA) and that their failure to comply is discriminatory against women and people with disabilities, and violates the ban against denying coverage based on health status or a pre-existing condition.

10 Nov 2015

Cancer survivors' journeys chronicled by Bethlehem artist and cancer survivor Susan Schaffer

Chronicling the journeys of cancer survivors, friends and family has been an emotional process, one filled with joy and shared sorrow for Bethlehem artist and cancer survivor Susan H. Schaffer. As part of her Visions of Hope series of acrylic paintings, Susan offers insight into the windows of the soul - her collection captures the eyes of the people willing to share their respective cancer journeys with her.

9 Nov 2015

Presence of tophi in people with gout can increase risk of developing cardiovascular disease

The presence of tophi - crystal deposits of uric acid found on the surface of the joints or in the skin and cartilage - in people with gout can increase their risk of developing cardiovascular disease, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco.

9 Nov 2015

Nightstar announces $35 million Series B financing round

NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.

9 Nov 2015

Study explores prevalence of myocardial scars in middle-aged and older population

In a multiethnic, middle-aged and older study population, the prevalence of myocardial scars (evidence of a heart attack) was nearly 8 percent, of which nearly 80 percent were unrecognized by electrocardiography or clinical evaluation, according to a study in the November 10 issue of JAMA.

9 Nov 2015

No progression in joint damage in 84% of psoriatic arthritis patients

Novartis announced today new results for Cosentyx® (secukinumab) showing no further progression in joint damage in 84% of patients with psoriatic arthritis (PsA). In addition, Cosentyx maintained a treatment response in joint and skin disease, physical function and quality of life in patients over two years of treatment. These results from the extension phase of the FUTURE 1 study were presented at the 2015 Annual Meeting of the American College of Rheumatology (ACR) in San Francisco, United States.

9 Nov 2015

Heart attack patients diagnosed and treated for diabetes experience improved cardiac outcomes

People with heart problems often have diabetes, which puts them at greater risk for heart attacks, heart failure and stroke. Now, a new study has found that ensuring heart attack patients are promptly diagnosed and treated for diabetes makes a significant difference in improving their cardiac outcomes.

9 Nov 2015

Energy drink consumption linked with serious cardiovascular events

Anna Svatikova, M.D., Ph.D., of the Mayo Clinic, Rochester, Minn., and colleagues randomly assigned 25 healthy volunteers (age 18 years or older) to consume a can (480 mL; 16 fl. oz.) of a commercially available energy drink (Rockstar; Rockstar Inc) and placebo drink within 5 minutes, in random order on 2 separate days, maximum 2 weeks apart.

9 Nov 2015

Diabetes drug liraglutide ineffective in patients with advanced heart failure

In an attempt to correct defects in the energy generation that contributes to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure. Despite improvements in blood sugar control, the therapy did not improve the clinical stability or pumping action of the heart in patients with advanced heart failure.

9 Nov 2015

Novartis’ Cosentyx® show no progression in spinal damage in 80% of ankylosing spondylitis patients

Novartis announced today late-breaking two year results for Cosentyx® (secukinumab) showing up to 80% of patients with ankylosing spondylitis (AS) had no radiographic progression in the spine on x-ray assessment. This is the first time that data on structural spinal progression in AS have been presented for an interleukin-17A (IL-17A) inhibitor.

9 Nov 2015

Medical Condition News

Brief manualized treatment helps people with problematic caffeine use lower caffeine consumption

Type 2 diabetes drug significantly reduces hospitalizations, death from heart failure

Two studies explore potential new blood tests for Alzheimer's disease

Understanding how schizophrenia affects workings of the brain

Lower socioeconomic status significantly increases risk of pain following knee replacement

UT Southwestern's Helen H. Hobbs named recipient of Breakthrough Prize in Life Sciences

Australian researchers define key characteristics of metabolically healthy obese

Negative body image significantly increases obesity risk among adolescents

New review finds scant scientific evidence supporting use of cannabinoids in rheumatic diseases

New Cleveland Clinic study shows bariatric surgery is safe option for managing type 2 diabetes in overweight or mildly obese patients

Obesity groups take aim at states that deny coverage of obesity treatment under affordable care act

Cancer survivors' journeys chronicled by Bethlehem artist and cancer survivor Susan Schaffer

Presence of tophi in people with gout can increase risk of developing cardiovascular disease

Nightstar announces $35 million Series B financing round

Study explores prevalence of myocardial scars in middle-aged and older population

No progression in joint damage in 84% of psoriatic arthritis patients

Heart attack patients diagnosed and treated for diabetes experience improved cardiac outcomes

Energy drink consumption linked with serious cardiovascular events

Diabetes drug liraglutide ineffective in patients with advanced heart failure

Novartis’ Cosentyx® show no progression in spinal damage in 80% of ankylosing spondylitis patients

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News